Sign In
  • A-
  • A
  • A+
  • ع
  • A-
  • A
  • A+
  • ع
Pr André SYROTA, MD, PhD
Professor Emeritus at the University of Paris Sud
Former Chairman and CEO of Inserm, (French National Institute of Health and Medical Research)
Scientific Advisor at the Division of Life Sciences of the Cea (French Alternative Energies and Atomic Energy Commission)
Member of the french Academy of Technologies

Born in 1946, André SYROTA has been nominated Executive Director of the French national institute of health and medical research, Inserm, in October 2007. He becomes scientific advisor at the Cea in 2014 and chairman of several boards in 2015.

He previously was Director of the Life Sciences Division of the French Atomic Energy Commission (1993-2007). M.D., Ph.D., and Professor of Biophysics and Nuclear medicine at the University of Paris-Sud, he was also head of the Service hospitalier Frédéric Joliot (CEA, Orsay), one of the European leading nuclear medicine and medical imaging research institutes (1984-2007).

As a Director, André Syrota managed the scientific strategy of the Atomic Energy Commission in the fields of life sciences and biomedical research, on two main lines : first the study of the effects of ionizing radiation on living matter (DNA repair, cell cycle, radiation biology, radiation induced cancer and toxicology), and second the application of nuclear technologies to life sciences and health technologies (development of labelling techniques and new tracers, medical imaging, structural biology and protein engineering, biochips, proteomics, biomass).

His research activities in the Service Hospitalier Frédéric Joliot were focused on the development of non-invasive functional imaging methods in human, using Positron Emission Tomography, Single Photon Emission Tomography and Nuclear Magnetic Resonance. Major research topics are dealing with brain research (human brain mapping of cognitive functions, assessment of new therapies, psychiatry, etc…), cardiology, oncology and pharmacology.

As Chairman of Inserm he promoted basic research as well as clinical and translational research. He asked researchers for excellence in research; at the end of his mandate Inserm became the first biomedical research institute in Europe and the second in the world after the US National Institutes of Health. He is at the origin of the creation of the french Alliances. He proposed in 2009 the creation of the National Alliance for the Life Sciences and Health with all the medical universities, university hospitals, public agencies and health industry.

André Syrota is the author of more than 200 articles and 40 book chapters. He has been a member of various boards at the Ministry of research and national institutes. He has also been a member of scientific evaluation committees in the field of biophysics and medical technologies such as chairman of the National Consortium in Genomic Research and of the Institute of Structural Biology, (Grenoble). He was a member of the European Strategy Forum on Research Infrastructures (ESFRI) Biological and Medical Sciences Steering Group, (EU), of the ISTC Scientific Advisory Committee (Moscow), of CYCERON (Caen) and CERMEP (Lyon) imaging facilities, etc…). He is now chairman of several boards.

Executive positions

Director General (2007-2008), then Chairman and CEO of Inserm from 2009 to 2014.
President of the « Alliance nationale pour les sciences de la vie et de la santé » (Aviesan) from 2009 to 2014.
Vice-president of ScienceEurope (2011-2013).
Chairman of Ksilink (Centre Franco-Allemand de Recherche Translationnelle) since 2014
Chaiman of the « Institut Universitaire du cancer de Toulouse » since 2014
Chairman of the board of CEPH (Centre d'Etude du Polymorphisme Humain) since 2014
Chairman of the board of Cermep (Centre d'études et de recherche en imagerie médicale) since 2015
President of the Scientific International Advisory Board of CYROI (Cyclotron de la Réunion et de l'Océan Indien) since 1987.
Member of the board of the University of Sharjah since 2009.
Member of the board of Cyceron (medical cyclotron of Caen) from 1985 to 2014. 
President of the scientific commission of Inserm "Biophysique, technologies biomédicales et chirurgicales" (1991-1994).
Member of the national committee of the french universities, (biophysics and medical imaging) (1992-2006).
Member of the scientific committee of the Gustave-Roussy Institute (1992-1994). 
President of the Institute of Structural Biology in Grenoble (1993-2007).
President of the board of the national consortium for research in genomics (2006-2007).
President of the scientific committee of Cermep in Lyon (1994-2014).
Member of the Executive Council of the European Science Foundation (1997-2000).
Member of board of Hoescht-Marion-Roussel (1997-2002).
Member of the com for the coordination of French life sciences (1998-2005).
Scientific adviser of the  french association against myopathies (AFM) from 2003 to 2006.
Member appointed by the European Commission at the scientific advisory committee of the International Science and Technology Center, Moscow, since 2004.
Member appointed by the European Commission at the scientific advisory committee of the Science and Technology Center Ukraine, Kiiv, since 2006.
French Representative on behalf of the European Union at the European Strategy Forum on Research Infrastructures for Biological and Medical Sciences (2004-2009).
Member of the external advisory board of the european programme « Human Brain Project » (2012-2014).
Member of the scientific advisory board of the "Méditerranée Infection Foundation" in Marseille since 2015.